SUNNYVALE, Calif. , Nov. 21, 2016 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that it will participate in the Citi 2016 Global Healthcare Conference on Thursday, December 8, 2016 in New York City . Kevin Waters , Senior Vice President and Chief Financial Officer, will meet
SUNNYVALE, Calif. , Oct. 27, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the 2017 fiscal first quarter ended September 30, 2016 . "With our first quarter results we remain well-positioned to drive growth for both orders and revenue in the back half
SUNNYVALE, Calif. , Oct. 6, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal first quarter ended September 30, 2016 on Thursday, October 27, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m.
ASTRO Selects the Data for Center Stage at Largest Annual Meeting of Radiation Oncologists SUNNYVALE, Calif. , Sept. 27, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, 21 center study showed 97 percent of low- and intermediate-risk prostate
Innovations in Hardware and Software Solutions and New Clinical Data Reinforce the Benefits of Accuray Systems in Treating a Wide Range of Cancer Cases SUNNYVALE, Calif. , Sept. 22, 2016 /PRNewswire/ -- New data on the Accuray (NASDAQ: ARAY) CyberKnife® and TomoTherapy® Systems will be shared by
SUNNYVALE, Calif. , Sept. 6, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine , President and Chief Executive Officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 14, 2016 at 8:45 a.m.
Achieves Record Backlog of $405.9 Million as Q4 Gross Orders Increase 12 Percent Announces Fiscal 2017 Guidance SUNNYVALE, Calif. , Aug. 17, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2016 .
Next Generation Image-Guided Radiation Therapy Platform and Integrated Software Solutions are Now Available for Use by Clinicians in the European Union SUNNYVALE, Calif. , Aug. 9, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that it has CE marked its Radixact™ Treatment
Clinical Research on the CyberKnife® System, Including the Multileaf Collimator, Presented at Leading Scientific Meeting for Medical Physicists SUNNYVALE, Calif., August 4, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that more than 45 studies on the use of the CyberKnife®
Clinical Research Also Showcases Innovative Approaches to Expanding TomoTherapy Platform Functionality SUNNYVALE, Calif. , Aug. 4, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new studies demonstrating the TomoTherapy® System's leading-edge adaptive therapy
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
